Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Promoting clinical and patient-oriented research to identify the pathogenesis of amyotrophic lateral sclerosis

Mitsumoto H. and Turner MR., (2013), Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 14, 1 - 4

Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial

(2013), The Lancet Neurology, 12, 339 - 345

Unmasking of incipient amyotrophic lateral sclerosis by botulinum toxin therapy

Kent L. et al, (2013), Journal of Neurology, 260, 1166 - 1167

Unmasking of incipient amyotrophic lateral sclerosis by botulinum toxin therapy

Kent L. et al, (2013), Journal of Neurology, 260, 1166 - 1167

Controversies and priorities in amyotrophic lateral sclerosis

Turner MR. et al, (2013), The Lancet Neurology, 12, 310 - 322

Inflammation and neurovascular changes in amyotrophic lateral sclerosis

Evans MC. et al, (2013), Molecular and Cellular Neuroscience, 53, 34 - 41

Inflammation and neurovascular changes in amyotrophic lateral sclerosis

Evans MC. et al, (2013), Molecular and Cellular Neuroscience, 53, 34 - 41

Evaluation of a Health State Staging System Defined by Loss of Independence in Amyotrophic Lateral Sclerosis: Assessment in a Second Dataset

Hammond E. et al, (2013), NEUROLOGY, 80

Multi-Centre Clinical Trial Data Using the King's Amyotrophic Lateral Sclerosis (ALS) Staging System

Balendra R. et al, (2013), NEUROLOGY, 80

Validation of an Amyotrophic Lateral Sclerosis Staging System Using Clinical Trial Data

Jones A. et al, (2013), NEUROLOGY, 80

Whole-brain magnetic resonance spectroscopic imaging measures are related to disability in ALS

Stagg CJ. et al, (2013), Neurology, 80, 610 - 615

Increased premorbid physical activity and amyotrophic lateral sclerosis: Born to run rather than run to death, or a seductive myth?

Turner MR., (2013), Journal of Neurology, Neurosurgery and Psychiatry, 84

Multiple Kernel Learning Captures a Systems-Level Functional Connectivity Biomarker Signature in Amyotrophic Lateral Sclerosis

Fekete T. et al, (2013), PLoS ONE, 8, e85190 - e85190

Motor neurone disease is a clinical diagnosis

Turner MR. and Talbot K., (2012), Practical Neurology, 12, 396 - 397

Fractional anisotropy in the posterior limb of the internal capsule and prognosis in amyotrophic lateral sclerosis.

Menke RAL. et al, (2012), Arch Neurol, 69, 1493 - 1499

Cerebrospinal fluid-based biomarkers for amyotrophic lateral sclerosis

Bowser R. et al, (2012), Amyotrophic Lateral Sclerosis and the Frontotemporal Dementias, 249 - 263

Multi-component relaxation reveals distinct patterns of white matter involvement in primary progressive multiple sclerosis and primary lateral sclerosis

Kolind S. et al, (2012), MULTIPLE SCLEROSIS JOURNAL, 18, 169 - 169

Teaching Video NeuroImages: Acute Adie syndrome

Wakerley BR. et al, (2012), Neurology, 79, e97 - e97

Young-onset amyotrophic lateral sclerosis: historical and other observations

Turner MR. et al, (2012), Brain, 135, 2883 - 2891

Neuroimaging in amyotrophic lateral sclerosis

Turner MR. et al, (2012), Biomarkers in Medicine, 6, 319 - 337

Load More

«
...
9
10
11
12
13
14
15
...
»

Include forthcoming?